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Abstract
Background: A relational approach to autonomy refers to the way in which social conditions and relationships shape a
person’s self-identity and capacity in decision-making. This article provides an empirical account of how treatment choices
for women undergoing breast diseases care are fostered within the dynamics of their relationships with clinicians, family
members, and other aspects of their social environment.
Methods: This qualitative study recruited ten women undergoing treatment at a breast programme, and eight clinicians
supporting their care, in a private teaching hospital in New South Wales, Australia. Fourteen patient-clinician consultation
observations and 17 semi-structured interviews were conducted. Schema analysis of interview transcripts were
undertaken by a team of researchers and corroborated by observational fieldnotes.
Results: Relational identities of patients influenced the rationale for treatment decision-making. Patients drew on
supportive resources from family and medical advice from clinicians to progress with treatment goals. While clinicians
held much social power over patients as the medical experts, patients highlighted the need for clinicians to earn their
trust through demonstrated professionalism. Information exchange created a communicative space for clinicians and
patients to negotiate shared values, promoting greater patient ownership of treatment decisions. As treatment
progressed, patients’ personal experiences of illness and treatment became a source of self-reflection, with a
transformative impact on self-confidence and assertiveness.
Conclusion: Patients’ confidence and self-trust can be fostered by opportunities for communicative engagement and
self-reflection over the course of treatment in breast disease, and better integration of their self-identity and social values
in treatment decisions.
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Background
Patient autonomy in the context of healthcare refers to
the ability of individuals to independently determine the
path of their own treatment [1, 2]. It is a fundamental
principle of person-centred care, which promotes the re-
flection of patients’ personal values and preferences in
treatment decisions. The promotion of personal auton-
omy has focused on ensuring that patients are well in-
formed of the full range of options available to them,
including the benefits and consequences of treatment
choices. Removing barriers against patients’ ability to
make independent decisions, such as the potentially pa-
ternalistic and coercive pressures from clinicians and
close family members, are also emphasised [3–5].
The concept of relational autonomy arose from feminist
critiques of an over-individualised understanding of per-
sonal autonomy [6–9]. Individuals are socially embedded,
thus their identities are formed within the context of social
relationships and shaped by complex intersecting social de-
terminants, such as gender, class and ethnicity [6]. A nar-
row focus on individualist notions of self-determination
and independence can downplay the social conditions that
structure decisions made in healthcare settings [7]. These
include socially constructed power relationships, such as
gender norms that shape attitudes of body image and
health, socio-economic conditions that alter the access to
healthcare knowledge and services, and the lack of social
power that depletes self-trust and confidence to question
and challenge the opinions of treating doctors [7, 10].
At the same time, not all social conditions that under-
score autonomy are limiting, but rather, can foster a per-
son’s capacity to be autonomous. A ‘capabilities approach’
[11, 12] suggests that resources and opportunities in a per-
son’s relational world can provide a social environment
which strengthens self-identity, self-determination and au-
tonomy. Clinicians, close family members and carers are
‘important social others’ [12] in a patient’s treatment and
care. These social relationships can develop opportunities
for communication and social interactions that fosters pa-
tients’ active engagement and dialogue in treatment
decision-making [13–15].
Given the emphasis on social context and the condi-
tional environment in which individuals exist, relational
autonomy is best illustrated by studying the empirical set-
ting in which it is practised. The treatment of breast dis-
eases for women is an appropriate context for examining
relational autonomy in decision-making. Breast disease
care, including for breast cancer and benign tumours, is
complicated by the availability of multiple treatment op-
tions and a potentially lengthy care continuum [16–18].
Previous studies have noted the clinical as well as social
and personal issues that face women in deciding to
undergo the range and succession of adjuvant therapies
such as different types of surgery, chemotherapy, radiation
therapy, and hormone treatments. With each treatment
stage and the emerging medical options, there is often an
increasing uncertainty about patient and clinical out-
comes, and the marginal benefits of some treatments may
come with potential risks of complications and
side-effects [17, 19, 20]. The gendered concerns about
body image and sexuality, and the anxieties around the
well-being for loved ones while patients’ lives are inter-
rupted by illness, are often enmeshed in breast disease
treatment decision-making [17–19, 21].
In view of this, the need to ensure patients’ values and
preferences are met in treatment decision-making is par-
ticularly pronounced [19, 22]. This study provides an ac-
count of women’s treatment decision-making in breast
disease care as contextualised by the dynamics in their
key relationships with family and clinicians, and their
wider social environment.
Methods
This qualitative study took place at a breast program in a
private, not-for-profit teaching hospital, located on a uni-
versity campus in New South Wales, Australia. The study
was approved by the relevant human research ethics com-
mittee. The programme treats patients with invasive can-
cer, ductal carcinoma in situ (DCIS), and benign disease.
Patient recruitment was conducted according to a time-
frame sampling approach, which allocates a specifically
chosen window of time during which recruitment takes
place. It is a method of choice to avoid researcher or clin-
ician coercion in sampling decisions, and offers opportun-
ities for maximum variation among participants. The first
ten patients undergoing treatment at the study site that
consented to take part between August 2016 and January
2017 were sampled. Inclusion criteria stipulated that pa-
tients needed to be female, competent English speakers,
over the age of 18, and deemed physically and mentally
capable of participating by clinicians. Eight clinicians
within the programme who played a role in caring for one
or more of the patients were also recruited. Although the
focus of this article is on patients diagnosed with cancer
and their treatment decision-making, cases of both benign
disease and DCIS, were included to best demonstrate the
importance of relational factors that influence personal
capacity for decision-making. The demographic profile of
patients is provided in Table 1. All quotes attributed to
participants in the results section are de-identified by the
assignment of pseudonyms in italics.
Fourteen clinical consultations were observed to examine
patient-professional communication, including the timing
of discussions, the language used during consultations, and
the intentions expressed. Observation fieldnotes were
taken in order to support a fuller record of the observa-
tional event. Seventeen semi-structured interviews were
conducted with patients and clinicians separately following
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observed consultations, using an interview guide designed
by the research team (see Additional file 1). They lasted
approximately 45 min, and were audio-recorded and
notated, before being transcribed verbatim.
A schema analysis of transcribed data was conducted.
Schema analysis is a qualitative data analysis technique
that uses a summative approach to clarify textual data,
ensuring the essential elements of data are captured in
one, free flowing, narrative text, before being refined
into a representation of the core concepts inherent in
the data [23, 24]. Firstly, four researchers each provided
a succinct overview of the complete content of each
transcript, concentrating on the meaning of the text
from the perspective of the research participants and indi-
cating the text’s essential meaning for them. Secondly, the
four researchers worked collaboratively to succinctly
summarise and analyse together a sub-set of the dataset,
led by a senior academic experienced in schema analysis.
Team members compared and contrasted their individu-
ally crafted schema, to arrive at a consensus of opinion on
the most essential elements within each transcribed text.
Observational notes and interview transcripts were
considered corroboratively, with notations from observed
events enhancing the accuracy and add validity to the data
analysis process.
Findings presented in this article concentrate on the
patient’s perspective. Clinicians’ perspectives and obser-
vational data, when applicable, are introduced to con-
textualise the patients’ views.
Results
The study results are assembled into five main themes: rela-
tional identities and relational resources, clinician-patient
relationships, negotiating shared values, lack of clarifying
values, and gaining experience and self-reflection over-time.
Relational identities and relational resources
‘It was a matter of life and death. I want to live’ (Hillary).
The urgency to undergo treatment after an unexpected
cancer diagnosis is overwhelmingly understood by
women as a matter of personal survival. Even so, the im-
plications of survival were also defined in relation to
women’s socially and personally valued identities as
mothers, grandmothers, wives and partners in a family
unit: ‘I’ve got three beautiful girls … I just want to sur-
vive’ (Caitlyn), and: ‘I want to be here to see my grand-
daughter get married’ (Annette).
On the other hand, patients highlighted how their
loved ones reciprocated support in a time of vulnerabil-
ity and personal crisis. In recognition of their diminished
Table 1 Patient participants’ demographic profiles
Participant Pseudonym Age Stage/Diagnosis Treatment Plan and Sequence Marital status and children Employment status
Annette 56 Stage 2 cancer 1. Chemotherapy
2. Lumpectomy
3. Radiation
Married; 3 adult children Full-time employed
Bonny 52 Stage 0 Ductal
Carcinoma in situ
(DCIS)
1. Lumpectomy
2. Radiation
Married; No children Full-time employed
Caitlyn 46 Stage 3 cancer 1. Chemotherapy
2. Lumpectomy
3. Radiation
Married; 3 dependent children Part-time employed
Diedre 55 Stage 2 cancer 1. Lumpectomy
2. Radiation
Divorced;1 dependent child Self-employed
Ella 35 Stage 2 cancer 1. Chemotherapy
2. Lumpectomy
3. Radiation
Married; 3 dependent children Self-employed
Frederika 64 Stage 1 cancer 1. Lumpectomy
2. Radiation
Separated; 2 adult children Full-time employed
Gladys 68 Stage 1 cancer 1. Mastectomy
2. Chemotherapy
3. Radiation
Married; 2 adult children Retired
Hillary 72 Stage 2 cancer First cancer (right breast)
1. Chemotherapy
2. Lumpectomy
3. Radiation
Second cancer (left breast)
1. Mastectomy
Married; 3 adult children Retired
Ingrid 28 Fibroadenoma
(benign breast lump)
1. Lumpectomy Married; No children Part-time employed
Jane 34 Stage 2 cancer 1. Lumpectomy
2. Radiation
Married; No children Full-time employed
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capacity for making reasoned decisions at a time of emo-
tional upheaval as they learn about a cancer diagnosis,
patients drew emotional and logistical support from
close family members to help them make progress in
treatment. Annette ‘didn’t want to see anyone or do any-
thing’ in the days following diagnosis, and it was her
adult son who contacted the oncologist on her behalf to
initiate the first treatment assessment. Ella relied on her
husband and sister-in-law to take notes during her on-
cology consultations as she was: ‘too messed up to take
anything in’, while Caitlyn delegated to her husband to
synthesise treatment information for her when she felt
that ‘too much detail was too scary’ at a time of height-
ened anxiety. As some patients acknowledged that their
own sense of judgement was compromised by the
trauma of an unexpected cancer diagnosis, family sup-
port enabled them to keep focussed on the need to begin
treatment and: ‘think clearly’ (Ella).
Apart from close family, the workplace also became an
important source of support. Other than two retirees, all
patients were engaged in a professional career that they
valued as part of their self-identity, and noted their ap-
preciation for colleagues and employees who were will-
ing to provide them with extended sick leave and
emotional encouragement while cancer treatment inter-
rupted their careers and lives.
Notably, the stage of breast disease at the time of diag-
nosis was not found to be the determining factor of a
patient’s feeling of shock and perceived impairment in
decision-making, nor their level of need in reliance and
support from family and the wider community. Rather,
each patient’s personal situation and quality of
inter-personal relationships determined this dynamic.
Clinician-patient relationships: a communicative space for
building trust
Patients’ relationships with their clinicians is a crucial part-
nership, and evolved over the course of clinical treatment.
As trained professionals with specialised medical know-
ledge and expertise in breast disease, clinicians according
to many accounts occupy a socially privileged position of
power in relation to their patients [7, 25]. This power rela-
tionship was particularly evident at the start of the treat-
ment, as patients were new to understanding their
diagnosed disease and looked for expert direction and ad-
vice. However, they must also facilitate the development
of trust through their interaction with patients.
In the observed clinical consultations, clinicians rou-
tinely provided patients with technical information in re-
lation to their disease and diagnosis, such as details of
tumour type, tumour size, position, and stage of inva-
siveness, and the risks and benefits of the treatment op-
tions available. Yet when interviewed, patients rarely
mentioned the technical details of prognosis and
treatment conveyed by clinicians. Instead, many noted
the trust and confidence they bestowed upon clinicians
to lead the treatment decisions, and highlighted profes-
sional thoroughness and scientific knowledge demon-
strated by clinicians in the way they provided the
rationale for the treatment plans: ‘[Clinician] knew what
he was talking about. He has written a book, after all’
(Bonny). The perception of professionalism and compe-
tence demonstrated by clinicians in this respect, gave pa-
tients a sense of relief that their health and survival was
in the hands of: ‘the best team’ (Ella).
What patients most valued in these clinical consulta-
tions, rather than the content of the medical information
discussed, was the chance to establish ‘trust and rapport’
with clinicians, especially at the start of a life-altering
treatment journey. A chance to engage in what was
seemingly “small talk” with patients allowed clinicians to
understand a patient’s personal circumstances, lifestyle
and leisure activities, professional work demands and
family situation. This information was in fact crucial in
helping clinicians formulate and tailor treatment advice
to the patients’ personal circumstances at this particular
time in their lives. For example, the readiness and appro-
priateness for intensive and lengthy radiation therapy or
breast-preserving surgery may not be the same for a
younger patient in her 30s as it is for and older patient,
or a patient with an active lifestyle, professional work
load, or worried about fertility or caring for young chil-
dren. In turn, the early establishment of personal trust
and comfort with the medical team through interper-
sonal rapport was crucial in securing patients’ commit-
ment to progress with treatment.
Therefore, rather than questioning the legitimacy of the
treatment plans on offer or prognosis provided, patients
were more interested in ensuring that they played their
role in optimising treatment success. A large proportion
of questions posed by patients centred on the logistics of
treatment, such as the day-to-day practicalities of hospital
parking during regular treatment visits, scheduling treat-
ment visits to suit work arrangements, and how one can
manage side-effects of radiation or chemotherapy such as
skin-burning, hair-loss and nail-damage: ‘As long as they
tell me what to do - what lotions to put on it, drink water.
As long as they tell me what to do, I will do it.’ (Ella). For
patients, this was their way of reciprocating trust, by re-
assuring clinicians that they were also willing and commit-
ted to the treatment process.
An individualistic approach to patient autonomy takes
a functional and transactional view of information
provision, as a way to obtain patients’ informed choice
based on the rational deliberation of the cost and bene-
fits of treatment options [8, 10]. Therefore, the prefer-
ences of clinicians were seen as potentially interfering
with patient’s autonomy. However, patients in this study
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did not suggest that their adherence to clinicians’ guid-
ance was coercive, but rather, conditional, once they felt
clinicians had demonstrated professional competence
and deserved their trust. In fact, when presiding clini-
cians failed to quickly establish trust and confidence, pa-
tients became wary. One patient had deliberately sought
the second opinion of her current treating clinician,
when her first oncologist from another hospital failed to
communicate well with her, nor provided her with a
sense of confidence with their skills and knowledge. Ra-
ther than a passive recipient of clinicians’ directives, this
patient showed that she had a degree of power in ascer-
taining the appropriate medical team to steer her treat-
ment, despite admitting that by changing doctors and
hospitals, she had ‘upset the apple cart’.
Negotiating shared values
Clinicians gained patients’ trust not only by demonstrating
their professional expertise and grasp of medical know-
ledge. Their ability to facilitate a communicative space
opens an opportunity for dialogue between clinicians and
patients. This allowed clinicians and patients to acquaint
with each other’s values and points of view. For example,
clinicians detailed the treatment approach they advised,
based on their medical expertise and knowledge, while
giving patients an opportunity to express their values in
relation to their advice, and vice versa. The opportunity
for patients to ask questions was a way of seeking clarifica-
tion on information provided by clinicians and of opening
up a dialogue, where patients could also offer information
about themselves and their concerns.
The subtext of the two-way exchange during consulta-
tions was to build mutual understanding and a commit-
ment to work in partnership during the protracted
treatment process. As Sandman and Munthe suggest,
‘decision-making should be shared in order to expand the
possibilities for patient autonomy without abandoning the
patient or giving up the possibility to influence how the
patient is benefitted’ (p.290) [2]. Having an established
space for communication allowed clinicians and patients
to work out and negotiate decisions in such a way that pa-
tients’ and clinicians’ values became better aligned.
For example, clinicians who felt that patients’ prefer-
ences were not in their best interest were able to establish
a way to meet patients’ fundamental values in
decision-making. Ingrid, diagnosed with a benign tumour,
learnt about a cosmetic breast reconstruction practice that
made a surgical incision from the armpit, from a reality
television programme about plastic surgery, which she
understood was beneficial in reducing unsightly scaring.
The aesthetic preservation of Ingrid’s breasts was import-
ant for her because: ‘I don’t want to have any deformed
part of me … when it comes to your breasts – it’s my
favourite part of myself. So I don’t want it to be ugly.’
However, her clinician advised against this type of surgical
option, as he felt it was not appropriate for her and for the
position of her benign tumour, and told her that it would
damage healthy tissues unnecessarily. The clinician ex-
plained to Ingrid how the surgical option did not suit her
situation, and that the appearance of her breasts would be
minimally altered by his planned surgery that was isolated
to the nipple-areola region. Ingrid accepted this advice
over time, and settled with the original surgical plan, as
she felt reassured that the operation would cause minimal
scarring. This was an explanation that made Ingrid ‘feel
better’ about the decision, which she eventually described
as her ‘own choice’.
Through the opportunity for dialogue and exchange of
information about her values and preferences with her
clinician, Ingrid developed a better understanding of the
clinician’s reason for suggesting a more appropriate type
of surgery that would achieve a clinical outcome as well as
a cosmetic one. This communication process facilitated
Ingrid’s acceptance of a change to her plans and led to her
feeling a sense of ownership over the final treatment deci-
sion, even though the final decision about the type of sur-
gery differed to the one she originally envisaged.
Lack of clarifying values
There were exceptions to the negotiated and shared under-
standing described above, and times when a lack of clarifica-
tion of patients’ personal values about treatment decisions
in their relationship with family members and clinicians did
result in a less than ideal decision-making scenario.
Annette was deeply challenged by the conflicting pref-
erences of her adult daughter and her clinician about
the best type of surgical option. Initially, she was happy
to follow her clinician’s advice to undergo several
courses of chemotherapy to reduce the size of her
tumour in preparation for lumpectomy. This would have
allowed her to preserve most of her breast, instead of
the more drastic surgical option of mastectomy, which
her clinician felt was unnecessary given the location and
relatively small area of tumour invasion. However, dur-
ing chemotherapy, Annette’s distressed adult daughter
asked her to change her mind and undergo mastectomy,
to ensure a higher chance of survival, after seeing a
documentary about a high-profile American celebrity
who had undergone mastectomy to treat breast cancer.
Having had an emotional conversation with her daugh-
ter, Annette asked her clinician about this procedure, to
be told that the risk of cancer recurrence would be the
same for both types of surgery. While Annette settled
with the clinician’s advice, she began to doubt the reli-
ability of the information she was given by her clinician.
Pulled in several directions by her intersecting relation-
ships with her daughter and her clinician, she remained
unsure of what her own personal preference was.
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Without enough self-confidence, she was uncomfortable
with the decision to continue with chemotherapy and
lumpectomy, even though she remained compliant.
Gaining experience and self-reflection over-time
As patients progressed with breast disease care, they de-
veloped more understanding and experience of medical
treatment. Gradual progress towards achieving treat-
ment goals also added to a sense of self-confidence that
departed from the position of a novice and feelings of
vulnerability, which were more common at the begin-
ning of treatment. As Caitlyn explained: ‘Once treat-
ment started, I started to feel better psychologically,
because you feel like you’re taking control and you’re
fighting back.’
Over time, patients developed better awareness of their
own preferences and values in care options. According to
Ella, she had become more assertive in her current treat-
ment, having realised that her past experience of not ques-
tioning what turned out to be a misdiagnosis of another
disease by a previous doctor had not helped her case.
After her cancer diagnosis, she became worried about the
risk of having bone cancer linked to breast cancer, and the
chance of becoming pregnant during chemotherapy. Ella
requested additional assessments to rule out bone cancer,
and requested a referral to have her ovaries removed.
While her oncologist suggested that neither procedure
was necessary, as Ella’s risk of bone cancer was low and
the removal of ovaries was drastic and permanent, he
nevertheless supported her decision, given her insistence
and her desire not to have any more children. Ella felt that
the support demonstrated by her clinician gave her the
‘peace of mind’ to continue with breast cancer treatment.
At 72, Hillary was the oldest patient in the study, and
was undergoing treatment for a second cancer in her left
breast, just months after she concluded chemotherapy,
lumpectomy and radiation treatment for cancer in her
right breast. She felt her previous negative experience of
chemotherapy affected her decision to opt for a mastec-
tomy rather than chemotherapy during this second
treatment. At the beginning of her treatment of the right
breast, Hillary adhered to the advice of undergoing
chemotherapy. However, its side-effects turned out to be
debilitating. As a result, she was determined not to re-
ceive chemotherapy again, even though it was offered,
should she want to preserve the left breast. Instead, she
opted for a mastectomy as she ‘just wanted to get rid of
the whole thing’, rather than to have to endure the
side-effects of chemotherapy and 5 weeks of intensive
and tiring radiation treatment at her age.
Personal experience incrementally gained from treat-
ment helped patients gain clarity about their preferences
and values in terms of ongoing treatment choices. This
facilitated a sense of better control over the path of their
treatment and helped patients develop a stronger sense
of self-trust over time. However, this required clinicians,
as key players in treatment, to enable a communicative
space for patients to discuss and negotiate treatment
choices that may divert from standard medical advice,
and allow patients to feel at ease that their choices are
supported by medical professionals.
The study results also highlighted an interesting
phenomenon. The experience of confronting illness and
undergoing treatment can give rise to a transformative
shift in building assertiveness and self-trust in response.
Previously, Ella had adopted the socially accepted norm
of the patient who complied with clinicians’ directives.
However, in light of her negative experience of misdiag-
nosis, her attitude changed: ‘I’ve learned to push for
what I want now!’ Similarly, the experience of cancer
diagnosis gave Caitlyn the realisation that as a mother
over-burdened by her role as the primary carer, she had
neglected her own health in the interest of looking after
her young family:
Being a mother of three girls, I was putting myself last.
Now I realise that was so stupid … in order to look
after my family I need to put myself first. I feel like this
is a huge wakeup call and almost a bit of a gift in that
if this hadn't happened, I could have merrily gone
along … You never know.
Discussion
Relational autonomy emphasises the social conditions
and relationships that underscore a person’s self-identity
and capacity for decision-making. The decisional envir-
onment of a patient should be understood beyond iso-
lated events in the clinic, but as a part of a wider
narrative of illness, shaped by personal history and ex-
perience situated in a dynamic social world [26]. This
study illuminated the dynamic interplay between the
constraining and enabling social conditions that context-
ualise the formation of personal values and relational in-
teractions that lead to treatment decision-making. These
social conditions that limit and facilitate capacity for au-
tonomy are better conceptualised as a spectrum of fluid
interactions between constraining and enabling elements
of autonomy. In view of this, and arising from our re-
sults, four interlinked elements that constitute a person’s
relational environment are presented in Fig. 1. These are
(1) family and other personal relationships and identities;
(2) professional care-giving relationships; (3) the social
and situational context of illness and treatment; and (4)
patients’ self-reflection and personal growth during
treatment. The empirical examples of these conditions,
as examined in this study, are outlined in corresponding
boxes against each of the spectrums.
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The socially produced and largely gendered relational
identities of, for example, being a mother, partner and
career professional underscore women’s desire to
undergo treatment for breast disease (Spectrums 1 and
3). In turn, the social and relational resources offered by
“important social others” [12] such as family members,
friends and employers were crucial sources of support.
Patients’ need to rely on others in assisting with
decision-making arose from the self-recognition that
their capacity for rational decision-making is greatly di-
minished at a time of trauma and vulnerability [10].
However, this is not because of a lack of capacity for de-
liberative reasoning on the part of the patient, but the
active and reasoned use of relational resources by pa-
tients, drawing on the rational capacity of others in
whom they trust. This is in order to achieve treatment
Fig. 1 Four conditional spectrums of relational autonomy
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goals that are beneficial to not just patients, but also
their loved ones, who are immediately implicated by the
patient’s health and wellbeing.
Clinicians occupy a socially privileged position of
power in relation to lay patients [7, 25], to whom they
look for medical expertise for guidance (Spectrums 2
and 4). However, patients demonstrated considerable
discernment in response to the way which clinicians at-
tempt to build trust and establish interpersonal rapport.
It is the communicative skill of clinicians to open a
space for mutual exchange of information and values
that is most crucial. This promotes the ongoing collab-
orative approach to address and negotiate treatment de-
cisions and challenges as they arise. As Joseph-Williams,
Elwyn and Edwards [27] suggest, the knowledge gained
from information provision in routine clinical consulta-
tions does not necessarily help patients to participate
more fully in decision-making. Rather, it is the oppor-
tunity and encouragement to become more active and
engaged in the decision-making process that helps pa-
tients gain a sense of self-growth and autonomous cap-
acity. In view of this, patient-clinician communication
should be understood beyond the transaction of infor-
mation that simply supports patients’ informed
decision-making, to a process of strengthening the rela-
tional conditions for trust-building and negotiation of
shared values [11].
Socially produced gender norms that shape women’s
attitudes about body image and healthcare are reflected
in popular media and various internet-based information
sources. These conditions in the informational environ-
ment can influence the values and preferences of both
patients and close family on treatment decisions [26].
Family members and friends can play the role of ‘surro-
gate seekers of information’ on behalf of patients
(Spectrum 1 and 3) [28], but in turn can create undue
pressures and decisional conflicts for patients. These
pressures culminated in the case of Annette, whose de-
sire to engage with the preferences of her daughter and
her doctor came into conflict (Spectrums 1, 2, 3 and 4).
Given their position of power and influence, clinicians
can help patients clarify the values and emotions under-
pinning their preference for treatment, as well as the
values and beliefs of supportive others. In many cases,
treatment options not envisaged by patients may still en-
able patients to feel they have achieved their goals. Rather
than discourage patients from accessing internet-based in-
formation, in many cases clinicians can support patients’
ongoing information-seeking needs by guiding them in
appropriate information-selection that is suitable to their
own personal and medical circumstances [29]. Additional
evidence-based decisional resources are now increasingly
available for achieving these objectives. For example, the
Breast RECONstruction Decision Aid (BRECONDA) is an
interactive decision tool designed in Australia shown to
assist in clarifying patients’ values and preferences, and re-
ducing patient distress associated with decisional conflicts
when multiple options of treatment are available [17, 30].
Finally, a relational approach to autonomy highlights
the feminist concern that women’s decision-making can
be adversely influenced by constraining social norms and
power relationships [6, 7, 10, 31]. In this study, these in-
clude the pressure to conform to gendered expectations of
body image, the over-burden of the primary carer of chil-
dren, and the lack of confidence to question the authority
and knowledge of clinicians who hold a position of power.
In light of the social injustices revealed by a relational ap-
proach to autonomy, Sherwin [7] urges the need to trans-
form the “status quo” of structural patterns of social
condition and personal notions of selfhood that currently
constrain the autonomous capacity of women. This study
shows that women can develop a capacity to recognise
and question the socially conditioned limitations they ex-
perience during the course of living with illness and
undergoing treatment. In the case of Ella and Caitlyn, for
example, it is through reflecting on the experience of ad-
versity that gave rise to a self-realisation to prioritise their
own needs over those of others. This is both a personal
process of self-reflection (Spectrum 4), and a social
process of responding to opportunities or challenges in
the social structure within which a person exists
(Spectrum 3) [2, 12, 32]. Indeed, the social transformation
that challenges the status quo of gender norms and power
relations is taking place at the personal level, and in this
way, becomes meaningful in women’s everyday lives.
Conclusion
This study applies the concept of relational autonomy to
empirical qualitative data drawn from the setting of routine
clinical consultations around breast disease treatment. It
supports a person-centred approach to care, by illustrating
how patients’ experiences of treatment are contextualised
by personal relationships and life stories. Furthermore, their
encounters of illness and treatment in the clinic made vis-
ible both experiences of distress and sources of strength
that continues to transform their lives.
The results of the study developed a conceptual model
of four conditional spectrums of relational autonomy,
which can be transferred and applied to a range of other
social and situational contexts. The constraining and en-
abling conditions of relational autonomy can also be iden-
tified in different forms, with different patient cohorts and
types of treatment decisions. This is particularly salient,
given that relational autonomy is characterised by its sen-
sitivity to social contexts and conditions.
While this study is limited by being relatively modest
in scale, and set in a specific, socio-cultural location in
Sydney, Australia with English-speaking female patients
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who are 18 years or older, its strengths lie in its credibil-
ity, and the contextual illustration of relational auton-
omy. The findings nevertheless inform future, larger
scale studies that will include culturally and linguistically
diverse populations, and patients who may vary more in
age and financial status, to understand wider factors that
influence relational autonomy.
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to direct discussions with patients during interviews. (DOCX 13 kb)
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